Unknown

Dataset Information

0

Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.


ABSTRACT:

Objective

To evaluate the outcome of patients with ROCM (Rhino-orbito-cerebral mucormycosis) following their medical and surgical management.

Materials and methods

It is a prognostic study based in a tertiary care center in North-Western India. Patients who developed ROCM post COVID-19 infection from 1st September 2020 to 30th June 2021 were included in this study. Surgical debridement and administration of antifungal therapy was done for the post-COVID-19 ROCM patients. Disease progression and survival was studied up to 5 months of follow-up in the second wave.

Results

A total of 145 ROCM patients were included. The mean age at presentation, male: female ratio was 48.2 years and 2:1 respectively. As per our proposed new staging system and treatment strategy, the majority of patients belonged to stage II (31.72%) and stage III (31.03%). On a follow-up period of 5 months, 26 (18%) patients have lost their life and rest of the patients are on strict follow-up.

Conclusion

ROCM is an extremely aggressive fungal infection which rapidly became an epidemic following the COVID-19 pandemic. The diverse and unique presentation led us to evolve a new strategy to classify and manage these patients.

SUBMITTER: Soni K 

PROVIDER: S-EPMC8709922 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8282253 | biostudies-literature
| S-EPMC4976984 | biostudies-literature
| S-EPMC8010354 | biostudies-literature
| S-EPMC7405101 | biostudies-literature
| S-EPMC3318503 | biostudies-literature
| S-EPMC8324444 | biostudies-literature
| S-EPMC7733773 | biostudies-literature
| S-EPMC5973216 | biostudies-other
| S-EPMC5921832 | biostudies-literature
| S-EPMC7834458 | biostudies-literature